WHAT:
A team of U.S. and European researchers have found that a new vaccine strategy tested in mice provides stronger, more long-lasting protection from tuberculosis (TB) infection than the vaccine currently used in humans, known as BCG. Their fin…
Africa can feed itself. And it can make the transition from hungry importer to self-sufficiency in a single generation.
The startling assertions, in stark contrast with entrenched, gloomy perceptions of the continent, highlight a collection of …
ARLINGTON, VA– NOVEMBER 23, 2010 – – CONRAD is pleased to join in congratulating the Global iPrEx study team for their successful trial of oral tenofovir (TDF) with emtricitabine (FTC) for HIV prevention. Results of the National Institutes of He…
Conventional wisdom has long been negative on Africa. Historically, it has been seen as a failing continent, plagued by deep-rooted problems — poverty, corruption, war, and disease. But after four decades of relative stagnation, Africa has been g…
NAIROBI, KENYA (26 AUGUST 2010) — As climate change intensifies drought conditions in Africa and sparks fears of a new cycle of crippling food shortages, a study released today finds widespread adoption of recently developed drought-tolerant variet…
With over 40 million people worldwide currently living with HIV/AIDS and millions more becoming infected each year, a group of scientists is calling for a coordinated global HIV vaccine enterprise to speed up the development and testing of promising candidates. In an article in the June 27 issue of Science, the authors emphasize the urgent need for an HIV vaccine, and outline a plan to accelerate research. Without a vaccine, if current trends continue, 45 million new people will become infected by 2010 and 70 million people will die by 2020, the World Health Organization and the Joint United Nations Programme on HIV/AIDS predict.